Spruce Biosciences Inc (SPRB) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access SPRB Annual Balance Sheets →
Balance sheet performance over multiple periods helps investors evaluate the financial resilience of Spruce Biosciences Inc.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent96.30
Cash & Short-term Investments96.00
Other Current Assets0.23
Prepaid Expense, Current AS4.63
Total Current Assets101.15
Other Assets, Noncurrent1.70
Total Assets102.85
Liabilities
Accounts Payable, Current AC1.21
Accrued Liabilities, Current AC7.25
Long-term Debt, Current Maturities LO2.50
Other Liabilities, Current0.00
Total Current Liabilities10.96
Long-term debt19.94
Total Long-term Debt19.94
Derivative Liability, Noncurrent DE3.32
Other liabilities, Noncurrent0.00
Accrued Expenses And Other Current Liabilities8.10
Operating Lease Liability Noncurrent0.33
Total Liabilities19.12
Stockholders' Equity
Additional Paid In Capital Common Stock401.46
Retained Earnings / Accumulated Deficit-317.73
Other Equity0.00
Common Stockholder's Equity83.73
Total Stockholder's Equity83.73
Liabilities & Stockholder's Equity102.85
4 historic quarters locked

Sign in to unlock the full Spruce Biosciences Inc balance sheet history.

About Spruce Biosciences Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-345876

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.